Skip to content

A Comparison Between Continuous and Intermittent Intraabdominal Analgesia Using Local Anaesthetics

Phase IV Study of Postoperative Pain Management

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01492075
Acronym
PoPuLAR
Enrollment
40
Registered
2011-12-14
Start date
2008-01-31
Completion date
2010-06-30
Last updated
2015-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Hysterectomy

Keywords

Postoperative pain, Anesthetics: Local anesthetics, Surgery: Hysterectomy

Brief summary

The investigators hypothesis is that patient controlled local anesthetics administered intraabdominally are more efficacious compared to continuous infusion in reducing postoperative pain and morphine consumption.

Detailed description

Open abdominal hysterectomy is a common procedure performed for many benign and malignant gynaecological diseases and is associated with moderate to severe pain. Traditional methods for postoperative pain management include patient controlled intravenous analgesia (PCA) using morphine, epidural analgesia and spinal analgesia with opiates but recently, even local aesthetic (LA) has been used intra-abdominally and into the abdominal wall. Although epidural analgesia may be considered by some to be gold standard for pain relief following abdominal surgery, a recent publication and past experience over several years may question the use of invasive techniques for lower abdominal surgery. Thus, there is a trend towards movement from central blocks towards other non-invasive methods for pain relief. PCA with morphine is now commonly used for management of pain following major surgery and compared to central blocks, has advantages in being relatively safe, easy to use and associated with a high degree of patient satisfaction. However, the large doses of morphine necessary to ensure adequate postoperative analgesia means that side effects such as postoperative nausea and vomiting (PONV), tiredness, pruritus, headache and constipation may be a major problem in this group of patients. Therefore, alternative techniques to reduce morphine requirements are increasingly being used. These include the use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID) and recently local anaesthetics (LA). The latter have been found to result in morphine sparing by 30 - 40 % and even a reduction in postoperative nausea (PON). LA infused intraperitoneally is safe and effective and a recent study showed that using 12.5 mg/h levobupivacaine could attain adequate analgesia. Thus, efficacy of LA has been established as well as the dose. However, the method of administration of LA intraperitoneally remains unclear. This study is designed with the primary aim of studying whether morphine consumption can be reduced postoperatively using the patient-controlled administration system for intraperitoneal LA compared to a continuous infusion, and whether this translates into improved recovery parameters or reduced side effects and improved patient satisfaction.

Interventions

DRUGPCRA (Intermittent injection)

Intermittent injection of LA intraabdominally

Sponsors

Örebro University, Sweden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. 18 -65 year old patients undergoing open abdominal hysterectomy. 2. ASA I - II (Appendix 1). 3. Have signed and dated Informed Consent. 4. Willing and able to comply with the protocol for the duration of the trial.

Exclusion criteria

1. Patients undergoing open abdominal hysterectomy due to suspected cancer. 2. Patients with chronic pain who are taking analgesics regularly. 3. Allergy to components in levobupivacaine (Chirocaine)/Saline (Sodium Chloride). 4. Participation in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumption0-24 hTotal morphine consumption 0 - 24 h postoperatively

Secondary

MeasureTime frameDescription
Postoperative pain0 - 48 h postoperativelyPost-operative pain assessed on the basis of NRS (Numeric Rating Score).
PONV0 - 48 h postoperativelyIncidence of nausea and vomiting and anti-emetic requirement
Home discharge0-10 daysTime to home readiness and time to return to work.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026